Critical Transition and Reversion of Tumorigenesis

Cited 8 time in webofscience Cited 0 time in scopus
  • Hit : 110
  • Download : 0
DC FieldValueLanguage
dc.contributor.authorShin, Dongkwanko
dc.contributor.authorCho, Kwang-Hyunko
dc.date.accessioned2023-05-27T08:00:23Z-
dc.date.available2023-05-27T08:00:23Z-
dc.date.created2023-03-21-
dc.date.created2023-03-21-
dc.date.created2023-03-21-
dc.date.issued2023-04-
dc.identifier.citationEXPERIMENTAL AND MOLECULAR MEDICINE, v.55, no.4, pp.692 - 705-
dc.identifier.issn1226-3613-
dc.identifier.urihttp://hdl.handle.net/10203/306942-
dc.description.abstractCancer is caused by the accumulation of genetic alterations and therefore has been historically considered to be irreversible. Intriguingly, several studies have reported that cancer cells can be reversed to be normal cells under certain circumstances. Despite these experimental observations, conceptual and theoretical frameworks that explain these phenomena and enable their exploration in a systematic way are lacking. In this review, we provide an overview of cancer reversion studies and describe recent advancements in systems biological approaches based on attractor landscape analysis. We suggest that the critical transition in tumorigenesis is an important clue for achieving cancer reversion. During tumorigenesis, a critical transition may occur at a tipping point, where cells undergo abrupt changes and reach a new equilibrium state that is determined by complex intracellular regulatory events. We introduce a conceptual framework based on attractor landscapes through which we can investigate the critical transition in tumorigenesis and induce its reversion by combining intracellular molecular perturbation and extracellular signaling controls. Finally, we present a cancer reversion therapy approach that may be a paradigm-changing alternative to current cancer cell-killing therapies.-
dc.languageEnglish-
dc.publisherSPRINGERNATURE-
dc.titleCritical Transition and Reversion of Tumorigenesis-
dc.typeArticle-
dc.identifier.wosid001066758000002-
dc.identifier.scopusid2-s2.0-85151420569-
dc.type.rimsART-
dc.citation.volume55-
dc.citation.issue4-
dc.citation.beginningpage692-
dc.citation.endingpage705-
dc.citation.publicationnameEXPERIMENTAL AND MOLECULAR MEDICINE-
dc.identifier.doi10.1038/s12276-023-00969-3-
dc.identifier.kciidART002952722-
dc.contributor.localauthorCho, Kwang-Hyun-
dc.description.isOpenAccessN-
dc.type.journalArticleReview-
dc.subject.keywordPlusACUTE PROMYELOCYTIC LEUKEMIA-
dc.subject.keywordPlusTUMOR REVERSION-
dc.subject.keywordPlusNETWORK INFERENCE-
dc.subject.keywordPlusARSENIC TRIOXIDE-
dc.subject.keywordPlusFEEDBACK LOOPS-
dc.subject.keywordPlusRETINOIC ACID-
dc.subject.keywordPlusCANCER-
dc.subject.keywordPlusDIFFERENTIATION-
dc.subject.keywordPlusMUTATIONS-
dc.subject.keywordPlusSELECTION-
Appears in Collection
BiS-Journal Papers(저널논문)
Files in This Item
There are no files associated with this item.
This item is cited by other documents in WoS
⊙ Detail Information in WoSⓡ Click to see webofscience_button
⊙ Cited 8 items in WoS Click to see citing articles in records_button

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0